Codagenix, Inc. is a Cambridge-based company that specializes in engineering viruses to revolutionize global health. With their innovative synthetic biology-driven approach, they design precise edits into viral genomes, creating live-attenuated viruses that offer broad immunity benefits for infectious diseases and cancer, while ensuring unparalleled safety, efficacy, and scalability.
Leading the new era of live vaccines and viral therapeutics, Codagenix leverages cutting-edge codon deoptimization technology to develop timely vaccines for infectious diseases, groundbreaking cancer therapies, and solutions for animal health, contributing to a healthier planet. With a team of fearless pioneers, Codagenix is dedicated to tackling global health challenges head-on.
Generated from the website